Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and a crisp breeze is wafting by. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation. Our choice today is bourbon pecan. Meanwhile, here are a few items of interest. Have a grand day and drop us a line if you hear something saucy…
Aspen Pharmacare (APHNY) reached an agreement to package, sell, and distribute the Johnson & Johnson (JNJ) Covid-19 vaccine under its own brand in Africa, Reuters reports. J&J had contracted Aspen to package the Covid-19 vaccine drug substance into final doses, a process called fill and finish, and supply it back to J&J. This arrangement, however, did not give Aspen rights over who gets the vaccine and where it goes. In a separate statement, J&J said the agreement means that Aspen can now supply the Covid-19 vaccine under the Aspenovax brand to all 55 African countries and multilateral entities supporting Africa’s vaccination plan.
Create a display name to comment
This name will appear with your comment